Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone only pill
ConclusionsThis is the first report of a new drospirenone only oral contraceptive providing clinical efficacy like combined oral contraceptives, with a good safety profile, and favourable cycle control.This article is protected by copyright. All rights reserved.
Source: Acta Obstetricia et Gynecologica Scandinavica - Category: OBGYN Authors: Santiago Palacios,
Enrico Colli,
Pedro ‐Antonio Regidor Tags: Original Research Article Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Heart | Heart Attack | Laboratory Medicine | OBGYN | PET Scan | Pulmonary Thromboembolism | Statistics | Stroke | Study | Thrombosis | Women